But, Coetzee added, "This study illustrates that there are oral agents becoming available for people with MS. And, it brings hope that we will have a next generation of agents, and that we can hopefully stop the progression of MS."
More information
Learn more about multiple sclerosis from the National Multiple Sclerosis Society.
Copyright © 2012 HealthDay. All rights reserved.
















Reader Comments Read all comments (1)